Abcam and Genedata Collaborate to Accelerate AI-Driven Antibody Development at Global Scale

The partnership combines Abcam's expertise in antibody development with Genedata's proprietary data model and enterprise platform to enhance data connectivity, accelerate innovation, and help deliver high-quality reagents to researchers faster. BASEL, Switzerland, Sept. 3, 2026...